Peer support program for individuals with major depression

Peer-led Intervention for Individuals With Major Depression.

Not applicable Interventional University of the Balearic Islands · NCT06398561

This study is testing whether a peer support program can help people with major depression feel better compared to using an online mental health app.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment70 (estimated)
Ages18 Years to 85 Years
SexAll
SponsorUniversity of the Balearic Islands Academic / other
Locations1 site (Palma de Mallorca, Balearic Islands)
Trial IDNCT06398561 on ClinicalTrials.gov

What this trial studies

This clinical trial evaluates the effectiveness of a peer support intervention, known as the Active Patient Program, in reducing depressive symptoms compared to an online mental health app called COGITO. Conducted in Primary Care Mental Health Units in Mallorca, participants will be randomly assigned to either the peer support program or the control group receiving the app. The study aims to recruit individuals diagnosed with Major Depressive Disorder who are currently receiving care from mental health professionals. The trial will assess the impact of peer-led support on mental health outcomes.

Who should consider this trial

Good fit: Ideal candidates for this study are adults over 18 years old diagnosed with Major Depressive Disorder and actively receiving treatment from mental health professionals.

Not a fit: Patients with acute mental health disorders or those with significant mobility issues may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could provide a valuable alternative approach to managing major depression through peer support.

How similar studies have performed: Previous studies have shown promising results for peer support interventions in mental health, suggesting potential effectiveness for this approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Selection and withdrawal of subjects

Inclusion criteria:

* People over 18 years of age.
* Attending consultations with any of the professionals in the USM mental health network.
* Having an active diagnostic label of Major Depressive Disorder, according to ICD or DSM criteria in the Primary Care e-SIAP program or meeting MINI TRAS criteria after individual interview for Major Depressive Episode.

Exclusion criteria

* People who present mental health disorders associated with a depressive disorder and who are in the acute phase of the disease.
* People who are not under active follow-up with any of the professionals of the USM.
* People with mobility problems and / or displacement to the health center.
* People suffering from another disease affecting the CNS (organic brain pathology or who have suffered a severe head injury, onset dementia or any other neurodegenerative disease, etc.).
* People with presence of uncontrolled serious medical, infectious or degenerative disease, which may interfere with affective symptomatology.
* People with significant risk of suicide according to medical criteria, assessed through follow-up interviews conducted by mental health professionals of reference.
* People with any medical, psychological and/or social problem that could seriously interfere with the patient's participation in the study.
* People who are legally incapacitated to make health decisions.

Where this trial is running

Palma de Mallorca, Balearic Islands

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Depressive Disorder, Majorpeer-leaderpromotionmental healthdepressionpeer to peerhealth education
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.